TG Therapeutics宣布已完成现有股份回购计划的执行,同时获得董事会授权启动新的1亿美元股份回购方案。
该公司表示,此次新的股份回购计划将为公司提供更多资本配置的灵活性,体现了管理层对公司长期发展前景的信心。新的1亿美元回购授权将使公司能够根据市场条件和业务需要,适时回购公司股份。
TG Therapeutics宣布已完成现有股份回购计划的执行,同时获得董事会授权启动新的1亿美元股份回购方案。
该公司表示,此次新的股份回购计划将为公司提供更多资本配置的灵活性,体现了管理层对公司长期发展前景的信心。新的1亿美元回购授权将使公司能够根据市场条件和业务需要,适时回购公司股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.